Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Incyte INCY is building for the next decade Ticks Higher 20260508 Nuveen NKX Stock Bear Call Spread Slight Uptick 20260418 UBCP United Bancorp Inc reports Q4 2022 EPS of 04 dollars shares rise 018 percent in regular trading Market Recap Tech leads sector gains while consumer names trail broader equities Origin ORIQW Stock Annual Dividend Under Pressure 20260420 Shattuck Labs STTK Stock High Frequency Skyrockets 20260420 What AH Realty AHRT does that its rivals cannot replicate Q1 2026 Below Expectations Inside the NYT Bestseller List How Authors Attempt to Game the System and What It Means for the Publishing Industry Sen Kennedy Voices Support for Crypto Bill Potentially Shaping Regulatory Landscape Amesite AMST Q1 2026 In Line Whats Next for Investors Nasdaq Leads Decline as Oil and Borrowing Costs Weigh on Markets Ingevity Corporation NGVT Fell 448 Is a Recovery Ahead 20260515 BEL Dhanuka Agritech RITES Zydus Lifesciences Eureka Forbes Zee Q4 Results Unveiled Today US Payrolls Beat Expectations in April but Warning Signs Emerge GlobalFoundries Strong Q1 Performance Signals Growth Inflection Say Meridian Fund Managers SP 500 Edges Higher Led by Healthcare and Tech Comms Services Lags Berkshire Hathaway Rebuilds Airline Exposure With 26 Billion Delta Air Lines Stake Cautiously Optimistic on India Geosphere Capitals Arvind Sanger Eyes Earnings Revival for Market Momentum Corn Futures End Week on Positive Note Supported by Weather and Export Demand EMAT Q1 2026 Earnings Massive EPS Miss Amidst Opaque Revenue Picture Clipper Realty Inc CLPR Q1 2026 Earnings Profitability Achieved Amid Market Headwinds VFF Q1 2026 Earnings EPS Misses Estimates Amid Modest Profitability Stock Slides FormFactor Q1 2026 Earnings EPS Beats Estimates by Wide Margin WHLRL Q2 2024 Earnings Unanticipated EPS Surge Amid Limited Disclosure UVV Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions Kiniksa Pharmaceuticals Holds Steady Near 54 as Stock Tests Key Resistance Levels Prestige Consumer Healthcare PBH Holds Near 48 as Modest Decline Tests Support Zone Oriental Culture Holding OCG Bounces From Support Eyes Resistance at 192 Neuberger Next Generation Connectivity Fund Inc NBXG Surges 207 Testing Key Resistance Levels Douglas Dynamics PLOW Edges Higher Testing NearTerm Resistance Levels